Document is current
Any future updates will be listed below
-
Authors
Franken, André https://orcid.org/0000-0002-3508-5601
Kraemer, Annika
Sicking, Alicia
Watolla, Meike
Rivandi, Mahdi
Yang, Liwen
Warfsmann, Jens
Polzer, Bernhard M.
Friedl, Thomas W. P. https://orcid.org/0000-0002-4773-8067
Meier-Stiegen, Franziska
Stoecklein, Nikolas H.
Dayan, Davut
Riethdorf, Sabine
Mueller, Volkmar
Pantel, Klaus https://orcid.org/0000-0001-5736-2772
Koch, André
Hartkopf, Andreas D.
Krawczyk, Natalia
Ruckhaeberle, Eugen
Niederacher, Dieter
Fehm, Tanja
Neubauer, Hans https://orcid.org/0000-0002-3467-4105
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70112504, 70112504, 70112504, 70112504, 70112504, 70112504, 70112504, 70112504)
- License Information
-
More Information
Article History
Received: 19 August 2022
Revised: 16 January 2023
Accepted: 23 January 2023
First Online: 23 February 2023
Competing interests
: The authors declare no competing interests.
: All patients gave their written informed consent to use their blood samples for CTC analysis and translational research projects. Patients’ characteristics were anonymized with sample identifiers. They were enrolled into the Augusta study (approved by the Ethics Committee of the Medical Faculty of the Heinrich Heine University Düsseldorf; Ref-No.: 3430), the DETECT-III study (), the DETECT-IV study (), or the DETECT-V study ().
: Not applicable.
